PatternsRadar
Sign in

HCGHealthcare Global Enterprises Limited

NSE
Full chart
680.55INR+11.50 (+1.72%)Close · 6 Oct 2026
6 Aug 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹10,161 CrMarket cap
305.5P/E (TTM)
51.2%Delivery

Filings & corporate actions

46 results filed
CSV
Next results · Q2 FY27
Expected 9 Nov 2026 – 12 Nov 2026
Estimate: filed 40–43 days after quarter end, last 5 times
2026
  • 6 AugresultsResults · Q1 FY27 · consolidated and standalone-0.4%NSE
  • 14 JulshareholdingShareholding · 30 Jun 2026+1.1%NSE
  • 19 MayresultsResults · Q4 FY26 · consolidated and standalone+0.8%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026-0.4%NSE
  • 2 AprshareholdingShareholding · 27 Mar 2026-1.4%NSE
  • 2 MarrightsRights 1:17 @ Premium Rs 502/--2.7%
  • 5 FebresultsResults · Q3 FY26 · consolidated and standalone-4.8%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025+0.7%NSE

Reaction to results · all yearsrose on day 0 in 16 of 45 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY276 Aug 2026-0.4%+5.3%+3.2%1.5×
Q4 FY2619 May 2026+0.8%+2.0%-5.0%1.7×
Q3 FY265 Feb 2026-4.8%-2.5%-5.9%2.1×
Q2 FY2612 Nov 2025+0.5%-0.6%-5.7%0.9×
Q1 FY261 Aug 2025-0.1%+6.5%+13.4%1.8×
Q4 FY2524 May 2025-5.8%-7.7%-11.1%2.6×
Q3 FY2520 Feb 2025+5.3%+4.1%+13.0%0.6×
Q2 FY259 Nov 2024-0.6%0.0%+7.9%1.2×
Q1 FY258 Aug 2024+1.3%-0.6%+12.6%2.8×
Q4 FY2429 May 2024-1.0%-2.0%+5.1%0.6×
Q3 FY248 Feb 2024-0.2%+4.1%-9.4%3.4×
Q2 FY249 Nov 2023+0.8%-3.7%-2.2%4.1×
Q1 FY2410 Aug 2023+0.2%+2.1%+12.3%2.0×
Q4 FY2325 May 2023-3.4%+4.5%+5.2%1.9×
Q3 FY239 Feb 2023-1.8%-2.7%-5.5%2.3×
Q2 FY2310 Nov 2022-2.6%+5.2%-1.0%2.0×
Q1 FY2310 Aug 2022-2.7%-0.3%-5.5%3.0×
Q4 FY2226 May 2022+0.2%+2.9%+7.7%1.9×
Q3 FY2210 Feb 2022-2.9%-5.9%+8.7%1.1×
Q2 FY2211 Nov 2021-2.1%-5.4%-1.9%2.9×
Q1 FY2212 Aug 2021-3.9%-13.8%-5.9%1.2×
Q4 FY2117 Jun 2021-4.7%+8.6%+18.3%2.0×
Q3 FY2111 Feb 2021-0.9%+10.8%+13.5%3.1×
Q2 FY2113 Nov 2020+0.1%+17.2%+40.9%1.7×
Q1 FY2120 Aug 2020-0.8%-0.9%-6.1%2.6×
Q4 FY2029 Jul 2020-0.4%+1.4%+2.2%0.8×
Q3 FY2013 Feb 2020-1.7%-9.7%-21.5%5.1×
Q2 FY2011 Nov 2019-0.6%-2.3%-18.9%0.4×
Q1 FY208 Aug 2019+2.4%+8.9%+7.3%0.4×
Q4 FY1924 May 2019-1.1%-6.4%-17.3%1.8×
Q3 FY1919 Feb 2019+2.2%+1.0%+1.1%0.8×
Q2 FY1920 Nov 2018-1.3%-0.5%-9.8%0.4×
Q1 FY1927 Aug 2018+12.7%+5.1%-8.0%6.5×
Q4 FY181 Jun 2018-0.8%+0.5%+1.4%0.2×
Q3 FY1815 Feb 2018+4.0%-4.5%-4.9%4.8×
Q2 FY188 Nov 2017-0.1%+0.7%+1.8%0.2×
Q1 FY1821 Aug 2017+1.2%-0.2%-1.4%0.2×
Q4 FY1727 May 2017-2.8%+0.7%-3.2%1.8×
Q3 FY1610 Feb 2017-0.1%-1.3%-2.7%0.2×
Q3 FY179 Feb 2017+0.6%-1.6%-0.6%1.2×
Q2 FY1619 Nov 2016+0.1%+2.1%-3.0%1.5×
Q2 FY1719 Nov 2016+0.1%+2.1%-3.0%1.5×
Q1 FY163 Oct 2016-0.3%+0.5%+11.8%0.8×
Q1 FY173 Oct 2016-0.3%+0.5%+11.8%0.8×
Q4 FY1627 May 2016-0.7%-1.9%-6.6%0.6×
Average-0.4%+0.5%+0.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+13.4%
Profit YoY+175.3%
Interest cost YoY+2.8%
Revenue QoQ+6.6%
Profit QoQ+307.4%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+15.3%+14.6%+15.4%+18.1%+17.1%+14.5%
Profit-19.5%+21.0%-11.4%———

Key data

CSV
Open678.50
Day range652.80 – 683.80
52-week range513.30 – 804.65
From 52w high-15.4%
RSI (14)45.8
ATR (14)24.38
Volume1.15L
Avg volume (20D)1.30L
Rel volume0.89×
Volatility (1Y)31.6%
Turnover₹7.8Cr
SMA 50 / 200698.41 / 633.99

Delivery percentage

Latest · 6 Oct 202651.2%
20-day avg55.6%
1-year avg58.3%
Percentile (own history)26th
Range9.4–99.6%
Sessions1,731

Over the last 20 sessions HCG settled 55.6% of its traded quantity, which is above average for an NSE equity. Its one-year average is 58.3%, so recent sessions are running 2.7 points lower than usual. The latest session ranks higher than 26% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryHospital
PeersAPOLLOHOSPMAXHEALTHFORTISYATHARTHASTERDMMANIPALHOS

Performance returns

CSV
1D1W1M3M6M1Y
Price+1.72%-1.54%-3.26%+5.08%+28.97%+5.12%

Valuation

CSV
Market cap₹10,161 Cr
P/E (TTM)305.5
EPS (TTM)2.23
Shares outstanding14.93Cr
Listed30 Mar 2016

Ownership

CSV
Promoter64.21%
Promoter Δ QoQ0.00 pp
Public35.79%
FII2.74%
DII19.20%
Pledged5.17%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)646.9633.1652.3695.1
YoY chg+16.9%+13.5%+11.5%+13.4%
Net profit (₹ Cr)20.7(7.9)4.016.5
YoY chg-0.1%-201.9%-40.3%+175.3%
Net margin3.2%-1.2%0.6%2.4%
EPS1.16-0.680.150.92

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 64.21% · public 35.79%
30 Sept 2021: promoter 68.41%6 Dec 2021: promoter 71.02%31 Dec 2021: promoter 71.44%31 Mar 2022: promoter 71.43%30 Jun 2022: promoter 71.42%30 Sept 2022: promoter 71.39%31 Dec 2022: promoter 71.38%31 Mar 2023: promoter 71.37%30 Jun 2023: promoter 71.35%30 Sept 2023: promoter 71.30%31 Dec 2023: promoter 71.29%31 Mar 2024: promoter 71.28%30 Jun 2024: promoter 71.25%30 Sept 2024: promoter 71.23%31 Dec 2024: promoter 71.23%31 Mar 2025: promoter 71.22%30 Jun 2025: promoter 62.46%30 Sept 2025: promoter 63.78%31 Dec 2025: promoter 63.77%27 Mar 2026: promoter 64.21%31 Mar 2026: promoter 64.21%30 Jun 2026: promoter 64.21%
2021-092026-06
  • Promoter
  • Public and others
Promoter
64.21%
Public
35.79%
Promoter change
0.00 pp
Filed
14 Jul 2026
FII
2.74%
DII
19.20%
Promoter pledged
5.17%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations486.9469.9494.6525.6553.5557.6585.2613.2646.9633.1652.3695.1
Other income3.46.15.18.811.15.710.26.82.62.513.112.1
Total income490.3475.9499.7534.4564.7563.2595.4620.0649.5635.5665.4707.2
Total expenses472.4464.9475.4515.4537.0567.4581.7608.8630.0628.9632.8683.1
└ Finance costs26.929.526.833.736.040.744.245.543.644.842.739.9
└ Depreciation43.244.246.047.049.756.558.157.962.860.762.870.4
Profit before tax17.911.128.219.027.7(4.2)13.711.219.5(6.0)0.724.1
Tax expense7.17.64.85.47.0(11.1)6.95.9(0.8)1.8(2.8)8.6
Net profit10.83.423.513.620.77.86.86.020.7(7.9)4.016.5
EPS0.980.411.530.871.290.500.530.341.16-0.680.150.92
Net margin2.21%0.73%4.74%2.59%3.74%1.39%1.16%0.98%3.19%-1.25%0.62%2.37%
PBT margin3.68%2.36%5.69%3.62%5.00%-0.75%2.34%1.83%3.02%-0.95%0.11%3.47%
Tax rate39.82%68.93%16.90%28.21%25.18%—49.96%52.85%-4.31%—-382.19%35.56%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 6 Aug 2026.

HCG at a glance

  • HCG closed at ₹680.55 on 6 Oct 2026, +1.72% on the day, +5.1% over one year, 15.4% below its 52-week high of ₹804.65.
  • Delivery was 51.2% of traded quantity on 6 Oct 2026, the 26th percentile of its own 1,731 sessions with a reading (20-session average 55.6%, 1-year average 58.3%).
  • Market capitalisation is ₹10,161 crore at a trailing P/E of 305.5 (trailing EPS ₹2.23).
  • Q1 FY27 results (consolidated, filed 6 Aug 2026): revenue ₹695 crore (+13.4% year on year), net profit ₹16 crore (+175.3%); the price moved -0.4% on the first session after.
  • Promoters held 64.21% at 30 Jun 2026, unchanged on the previous filing, with 5.17% of promoter shares pledged.
  • Q2 FY27 results are expected between 9 Nov 2026 and 12 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryHospital
ISININE075I01017
SeriesEQ
Listed30 Mar 2016
History from30 Mar 2016
Sessions2,603

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Healthcare Services

CSV

All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE